This company has been marked as potentially delisted and may not be actively trading. OTCMKTS:BLUSF BELLUS Health (BLUSF) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About BELLUS Health Stock (OTCMKTS:BLUSF) 30 days 90 days 365 days Advanced Chart Get BELLUS Health alerts:Sign Up Key Stats Today's Range N/A50-Day Range$6.46▼$14.5152-Week Range N/AVolume3.45 million shsAverage Volume39,610 shsMarket Capitalization$2.35 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview BELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. Read More Receive BLUSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BELLUS Health and its competitors with MarketBeat's FREE daily newsletter. Email Address BLUSF Stock News HeadlinesTrying The Natural Blush TrickNovember 12, 2024 | msn.comNew trend alert! Amp up on the self-love and blush blindness with the adorable heart blush trendNovember 7, 2024 | msn.comBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change. July 7 at 2:00 AM | Crypto 101 Media (Ad)Is semi-permanent blush the next ‘it’ beauty trend?October 30, 2024 | msn.comIs semi-permanent blush the next ‘it’ beauty trend?October 30, 2024 | msn.comOur whole beauty team swears by this multi-tasking blush that will not budgeOctober 26, 2024 | msn.comI'm a makeup artist. I love the viral $23 Rare Beauty blush, but prefer this drugstore dupe for one-third of the price.October 23, 2024 | businessinsider.comTrending beauty products taking over this fall: Scalp scrubs, viral blush and more, from $6October 21, 2024 | msn.comSee More Headlines BLUSF Stock Analysis - Frequently Asked Questions How were BELLUS Health's earnings last quarter? BELLUS Health Inc (OTCMKTS:BLUSF) released its earnings results on Wednesday, May, 8th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by $0.01. The business had revenue of $0.01 million for the quarter. BELLUS Health had a negative net margin of 49,910.34% and a negative trailing twelve-month return on equity of 48.37%. Company Calendar Last Earnings5/08/2019Today7/07/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:BLUSF CIKN/A Webwww.bellushealth.com Phone45-0680-4500FaxN/AEmployees10Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.01 million Net Margins-49,910.34% Pretax MarginN/A Return on Equity-48.37% Return on Assets-45.25% Debt Debt-to-Equity RatioN/A Current Ratio13.87 Quick Ratio13.87 Sales & Book Value Annual Sales$30 thousand Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$0.25 per share Price / BookN/AMiscellaneous Outstanding Shares159,117,000Free FloatN/AMarket Cap$2.35 billion OptionableNot Optionable Beta1.55 Social Links The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (OTCMKTS:BLUSF) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BELLUS Health Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share BELLUS Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
